Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
Herrlinger KR, Witthoeft T, Raedler A, Bokemeyer B, Krummenerl T, Schulzke JD, Boerner N, Kueppers B, Emmrich J, Mescheder A, Schwertschlag U, Shapiro M, Stange EF.
Herrlinger KR, et al. Among authors: mescheder a.
Am J Gastroenterol. 2006 Apr;101(4):793-7. doi: 10.1111/j.1572-0241.2005.00356.x.
Am J Gastroenterol. 2006.
PMID: 16635225
Clinical Trial.